Elena M. Colombo

Department Of Head And Neck Medical Oncology
Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications

Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective Study.

Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective Study.

Journal: Thyroid : official journal of the American Thyroid Association
Published: June 24, 2026

The supporting role of Visual Evoked Potentials for the diagnosis of Optic Neuritis within the 2022 ICON criteria.

The supporting role of Visual Evoked Potentials for the diagnosis of Optic Neuritis within the 2022 ICON criteria.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 31, 2026

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.

Journal: Endocrine
Published: February 21, 2026

Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.

Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.

Journal: Journal of neurology
Published: February 12, 2026

Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouse.

Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouse.

Journal: ESMO real world data and digital oncology
Published: February 06, 2026

Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: post hoc insights from the C-POST and KEYNOTE-630 studies.

Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: post hoc insights from the C-POST and KEYNOTE-630 studies.

Journal: Immuno-oncology technology
Published: January 22, 2026

HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.

HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.

Journal: Journal of neurology
Published: December 05, 2025

A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis.

A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis.

Journal: Journal of medical cases
Published: November 26, 2025

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Journal: JAMA network open
Published: November 03, 2025

Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments.

Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments.

Journal: Journal of neurology
Published: November 03, 2025

Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis.

Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 08, 2025

Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocol.

Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocol.

Journal: Frontiers in public health
Published: August 18, 2025
Showing 1-12 of 82

Last Updated: 09/26/2026